International Panel Criteria (McDonald Criteria) for Diagnosis MS Clinical Presentation
http://tinyurl.com/8zwae
Additional Data Needed for MS Diagnosis
Two or more attacks; objective clinical evidence of 2 or more lesions None(a)
Two or more attacks; objective clinical evidence of 1 lesion
Dissemination in space demonstrated by:
* MRI(b), or
* 2 or more MRI lesions consistent with MS plus positive CSF(c), or
* await further clinical attack implicating a different site.
One attack; objective clinical evidence of 2 or more lesions
Dissemination in time demonstrated by:
* MRI(b), or
* second clinical attack.
One attack; objective clinical evidence of 1 lesion (clincally isolated syndrome)
Dissemination in space demonstrated by:
* MRI(b), or
* 2 or more MRI lesions consistent with MS plus positive CSF(c)
And dissemination in time, demonstrated by:
* MRI(b), or
* Second clinical attack
Insidious neurological progression suggestive of MS
Positive CSF(c), and dissemination in space,
demonstrated by:
* 1) 9 or more T2 lesions in brain, or 2) 2 or more lesions in spinal cord, or 3) 4-8 brain lesions plus 1 spinal cord lesion; or
* Abnormal visual evoked potentials with MRI demonstrating 4-8 brain lesions, or fewer than 4 brain lesions plus 1 spinal cord lesion; and
* Dissemination in time demonstrated by MRI(b); or
* Continued progression for 1 year
(a) Brain MRI is recommended to exclude other etiologies
(b) MRI criteria for dissemination in space or time are described in Table 2
(c) Positive CSF defined as oligoclonal bands different from those in serum, or raised IgG index.
Adapted from reference 6.
Copyright 2002 The Cleveland Clinic Foundation
Return to Multiple Sclerosis Chapter
http://www.clevelandclinicmeded.com/diseasemanagement/neurology/multsclerosis/table1ms.htm
Additional Data Needed for MS Diagnosis
Two or more attacks; objective clinical evidence of 2 or more lesions None(a)
Two or more attacks; objective clinical evidence of 1 lesion
Dissemination in space demonstrated by:
* MRI(b), or
* 2 or more MRI lesions consistent with MS plus positive CSF(c), or
* await further clinical attack implicating a different site.
One attack; objective clinical evidence of 2 or more lesions
Dissemination in time demonstrated by:
* MRI(b), or
* second clinical attack.
One attack; objective clinical evidence of 1 lesion (clincally isolated syndrome)
Dissemination in space demonstrated by:
* MRI(b), or
* 2 or more MRI lesions consistent with MS plus positive CSF(c)
And dissemination in time, demonstrated by:
* MRI(b), or
* Second clinical attack
Insidious neurological progression suggestive of MS
Positive CSF(c), and dissemination in space,
demonstrated by:
* 1) 9 or more T2 lesions in brain, or 2) 2 or more lesions in spinal cord, or 3) 4-8 brain lesions plus 1 spinal cord lesion; or
* Abnormal visual evoked potentials with MRI demonstrating 4-8 brain lesions, or fewer than 4 brain lesions plus 1 spinal cord lesion; and
* Dissemination in time demonstrated by MRI(b); or
* Continued progression for 1 year
(a) Brain MRI is recommended to exclude other etiologies
(b) MRI criteria for dissemination in space or time are described in Table 2
(c) Positive CSF defined as oligoclonal bands different from those in serum, or raised IgG index.
Adapted from reference 6.
Copyright 2002 The Cleveland Clinic Foundation
Return to Multiple Sclerosis Chapter
http://www.clevelandclinicmeded.com/diseasemanagement/neurology/multsclerosis/table1ms.htm
0 Comments:
Post a Comment
<< Home